I don't know the timeline, but at the AGM I think it was Ken Taylor who when asked about DIABECELL said that DOL had spent "scores of millions probably more" on refining the product in readiness for an FDA application, now I can't recall if that application has been made already. This kind of progess surely should have been communicated to the market, if LCT had any interest in their SP.
AGM, page-67
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
